These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27102492)

  • 1. The relationship of cognitive performance to concurrent symptoms, cancer- and cancer-treatment-related variables in women with early-stage breast cancer: a 2-year longitudinal study.
    Lyon DE; Cohen R; Chen H; Kelly DL; Starkweather A; Ahn HC; Jackson-Cook CK
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1461-74. PubMed ID: 27102492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of systemic cytokine concentrations to cognitive function over two years in women with early stage breast cancer.
    Lyon DE; Cohen R; Chen H; Kelly DL; McCain NL; Starkweather A; Ahn H; Sturgill J; Jackson-Cook CK
    J Neuroimmunol; 2016 Dec; 301():74-82. PubMed ID: 27890459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years.
    Gullett JM; Cohen RA; Yang GS; Menzies VS; Fieo RA; Kelly DL; Starkweather AR; Jackson-Cook CK; Lyon DE
    Psychooncology; 2019 May; 28(5):997-1003. PubMed ID: 30761683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological performance in survivors of breast cancer more than 20 years after adjuvant chemotherapy.
    Koppelmans V; Breteler MM; Boogerd W; Seynaeve C; Gundy C; Schagen SB
    J Clin Oncol; 2012 Apr; 30(10):1080-6. PubMed ID: 22370315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among psychoneurological symptoms and levels of C-reactive protein over 2 years in women with early-stage breast cancer.
    Starkweather A; Kelly DL; Thacker L; Wright ML; Jackson-Cook CK; Lyon DE
    Support Care Cancer; 2017 Jan; 25(1):167-176. PubMed ID: 27599815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive complaints after breast cancer treatments: examining the relationship with neuropsychological test performance.
    Ganz PA; Kwan L; Castellon SA; Oppenheim A; Bower JE; Silverman DH; Cole SW; Irwin MR; Ancoli-Israel S; Belin TR
    J Natl Cancer Inst; 2013 Jun; 105(11):791-801. PubMed ID: 23606729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
    Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
    Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trajectories of self-reported cognitive function in postmenopausal women during adjuvant systemic therapy for breast cancer.
    Merriman JD; Sereika SM; Brufsky AM; McAuliffe PF; McGuire KP; Myers JS; Phillips ML; Ryan CM; Gentry AL; Jones LD; Bender CM
    Psychooncology; 2017 Jan; 26(1):44-52. PubMed ID: 26486371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series.
    Galantino ML; Greene L; Daniels L; Dooley B; Muscatello L; O'Donnell L
    Explore (NY); 2012; 8(2):127-35. PubMed ID: 22385567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in early breast cancer.
    Groenvold M
    Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraindividual variability in reaction time before and after neoadjuvant chemotherapy in women diagnosed with breast cancer.
    Yao C; Rich JB; Tirona K; Bernstein LJ
    Psychooncology; 2017 Dec; 26(12):2261-2268. PubMed ID: 28002893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study.
    Tager FA; McKinley PS; Schnabel FR; El-Tamer M; Cheung YK; Fang Y; Golden CR; Frosch ME; Habif U; Mulligan MM; Chen IS; Hershman DL
    Breast Cancer Res Treat; 2010 Aug; 123(1):25-34. PubMed ID: 19894112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive dysfunction and symptom burden in women treated for breast cancer: a prospective behavioral and fMRI analysis.
    Jung MS; Zhang M; Askren MK; Berman MG; Peltier S; Hayes DF; Therrien B; Reuter-Lorenz PA; Cimprich B
    Brain Imaging Behav; 2017 Feb; 11(1):86-97. PubMed ID: 26809289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study of donepezil in female breast cancer survivors with self-reported cognitive dysfunction 1 to 5 years following adjuvant chemotherapy.
    Lawrence JA; Griffin L; Balcueva EP; Groteluschen DL; Samuel TA; Lesser GJ; Naughton MJ; Case LD; Shaw EG; Rapp SR
    J Cancer Surviv; 2016 Feb; 10(1):176-84. PubMed ID: 26130292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cognitive function of older patients receiving adjuvant chemotherapy for breast cancer: a pilot prospective longitudinal study.
    Hurria A; Rosen C; Hudis C; Zuckerman E; Panageas KS; Lachs MS; Witmer M; van Gorp WG; Fornier M; D'Andrea G; Moasser M; Dang C; Van Poznak C; Hurria A; Holland J
    J Am Geriatr Soc; 2006 Jun; 54(6):925-31. PubMed ID: 16776787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perceived cognitive impairment in people with colorectal cancer who do and do not receive chemotherapy.
    Dhillon HM; Tannock IF; Pond GR; Renton C; Rourke SB; Vardy JL
    J Cancer Surviv; 2018 Apr; 12(2):178-185. PubMed ID: 29080061
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive effects of chemotherapy in breast cancer patients: a dose-response study.
    Collins B; MacKenzie J; Tasca GA; Scherling C; Smith A
    Psychooncology; 2013 Jul; 22(7):1517-27. PubMed ID: 22936651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery from chemotherapy-induced white matter changes in young breast cancer survivors?
    Billiet T; Emsell L; Vandenbulcke M; Peeters R; Christiaens D; Leemans A; Van Hecke W; Smeets A; Amant F; Sunaert S; Deprez S
    Brain Imaging Behav; 2018 Feb; 12(1):64-77. PubMed ID: 28102529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cognitive sequelae of standard-dose adjuvant chemotherapy in women with breast carcinoma: results of a prospective, randomized, longitudinal trial.
    Wefel JS; Lenzi R; Theriault RL; Davis RN; Meyers CA
    Cancer; 2004 Jun; 100(11):2292-9. PubMed ID: 15160331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of adjuvant treatment on cognitive function in women with early breast cancer.
    Hedayati E; Alinaghizadeh H; Schedin A; Nyman H; Albertsson M
    Eur J Oncol Nurs; 2012 Jul; 16(3):315-22. PubMed ID: 21908235
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.